The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1212
July 4, 2005
View Complete Issue         Table of Contents 2019 
CYP3A and Drug Interactions
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
CYP3A and Drug Interactions
July 4, 2005 (Issue: 1212)
Serious adverse interactions between drugs continue to be reported. Many of these are due to inhibition or induction of cytochrome P450 (CYP) enzymes, particularly CYP3A4. CYP3A is thought to be involved in the metabolism of more than 50 percent of...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: CYP3A and Drug Interactions
Article code: 1212b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.